Mrs. Gana R Nadiga, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 405 E Pinecrest Dr Unit A, Marshall, TX 75670 Phone: 903-938-8581 Fax: 903-938-9409 |
News Archive
ImmunoGen, Inc., a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate technology, today announced that Novartis has licensed the exclusive right to use the Company's ADC technology to develop anticancer therapeutics to an undisclosed target.
The United States Patent and Trademark Office (USPTO) has granted and issued Advaxis, Inc. (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) vaccine company, patent 7,588,930 "Compositions and Methods for Enhancing Immunogenicity of Antigens." This patent expands the Company's intellectual property portfolio to cover another family of adjuvant proteins based upon the Lm protein Act-A.
Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.
In the April 1 issue of G&D, a Korean research team led by Dr. Kyong-Tai Kim (Pohang University) describes how melatonin production is coordinated with the body's natural sleep/wake cycles.
The Associated Press: The first detailed national estimate on complications in medical device use by children says that more than 70,000 kids a year have to go to emergency rooms because of complications from medical devices, with contact lenses the leading culprit. "About one-fourth of the problems were things like infections and eye abrasions in contact lens wearers.
› Verified 6 days ago